Business · 29/08/2006
FDA Announces Draft Guidance on Emergency Research Exemptions
The Food and Drug Administration (FDA) has released a draft guidance document to help Institutional Review Boards, clinical investigators, and sponsors navigate emergency research exemptions from informed consent requirements, as part of a broader public hearing on the topic.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →